New hope for tough prostate cancer: first human trial of VIR-5500 begins
NCT ID NCT05997615
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests a new drug called VIR-5500 in people with advanced prostate cancer that has stopped responding to hormone treatment. The main goals are to check the drug's safety and find the right dose, while also seeing if it can shrink tumors or lower PSA levels. About 437 participants will receive VIR-5500 alone or with another therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Investigational Site Number: 100
RECRUITINGMelbourne, 3000, Australia
-
Investigational Site Number: 101
RECRUITINGSydney, 2010, Australia
-
Investigational Site Number: 250
RECRUITINGBarcelona, 08035, Spain
-
Investigational Site Number: 251
WITHDRAWNBarcelona, 08023, Spain
-
Investigational Site Number: 252
RECRUITINGMadrid, 28223, Spain
-
Investigational Site Number: 253
RECRUITINGPamplona, 31008, Spain
-
Investigational Site Number: 254
RECRUITINGMadrid, 28027, Spain
-
Investigational Site Number: 300
RECRUITINGLondon, SM2 5PT, United Kingdom
-
Investigational Site Number: 400
RECRUITINGSeattle, Washington, 98109, United States
-
Investigational Site Number: 401
RECRUITINGHouston, Texas, 77030, United States
-
Investigational Site Number: 403
RECRUITINGPalo Alto, California, 94304, United States
-
Investigational Site number: 404
RECRUITINGFairfax, Virginia, 22031, United States